Replies to post #104867 on Biotech Values

[rkrw]

How would you know it's BS?

TEVA CEO keeps talking bs about his expectation for its mL approval soon and some bastard analysts believe him.

What we know is both Teva and mnta filed way back when and the FDA asked both for immunogenicity data. They both responded. mnta responded a little sooner than teva.

[alertmeipp]

the sad thing is even with multiple generics, we are looking at around 10-15 P/E for a company that has tremendous opportunities ahead.

I agree. MM is probably accumulating shares for some.

[DewDiligence]

Market makers doing nefarious things to subdue the share price is a silly fantasy that has no place on this board. Thank you in advance for your cooperation.